In this article (Mol Cancer Res 2016;14:1243–53), which was published in the December 2016 issue of Molecular Cancer Research (1), two errors affected data shown in Fig. 3.

First, in Fig. 3E, the representative BLI images of tumor-bearing mice were compiled incorrectly. Specifically, a duplicate BLI image (i.e., first and last image, from left to right) was used to represent mice for the Hpse-Tg genotype. The panel has been corrected, below, to show all mouse images for all genotypes used in the experiment.

Second, in Fig. 3F, the statistical analysis of quantified BLI signals obtained from day 19 mice (shown in corrected Fig. 3E, above) was incorrectly determined using a one-way ANOVA. The BLI signals used and corresponding graph in this panel have not changed; however, the P values have been revised according to a two-way ANOVA. The previously published and corrected P values are provided in the table below.

Compared groupsIncorrect previously published resultsCorrected results
wt vs. Hpse-KO ** NS 
Hpse-KO vs. Hpse-Tg *** ** 
wt vs. Hpse-Tg ** NS 
Compared groupsIncorrect previously published resultsCorrected results
wt vs. Hpse-KO ** NS 
Hpse-KO vs. Hpse-Tg *** ** 
wt vs. Hpse-Tg ** NS 

NOTE: NS, P > 0.05; *, P ≤ 0.05, **, P ≤ 0.01; ***, P ≤ 0.001.

The corrected panel is shown below.

These errors do not alter the main conclusions of this study. The online version of the article has been changed to reflect the content of this correction. The authors regret these errors.

1.
Kundu
S
,
Xiong
A
,
Spyrou
A
,
Wicher
G
,
Marinescu
VD
,
Edqvist
PD
, et al
Heparanase promotes glioma progression and is inversely correlated with patient survival
.
Mol Cancer Res
2016
;
14
:
1243
53
.